Both in Pharmaceuticals
Theriva Biologics vs Lexaria Bioscience
Over the past year TOVX returned −45.4% and LEXX returned −77.2%; their daily moves had a correlation of 0.01.
TOVX −45.4% LEXX −77.2%Growth of $1, one year, split-adjusted
| Metric | TOVX | LEXX |
|---|---|---|
| Price | $0.1705 | $3.49 |
| Market cap | $7.8M | $7.4M |
| Today | −8.82% | −7.43% |
| 1 month | −24.2% | +12.9% |
| 6 months | −56.2% | −67.3% |
| Year to date | −19.0% | −62.3% |
| 1 year | −45.0% | −75.7% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 26.1× | 37.9× |
| Net cash | $9.7M | $3.6M |
| Dividend yield | — | — |
| Volatility (60d) | 49.3% | 194.3% |
| Short % of float | 4.0% | 16.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).